Frontiers | Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules | Microbiology
Pharmacology of letermovir and maribavir. | Download Scientific Diagram
Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance - ScienceDirect
Antiviral Drug Resistance of Human Cytomegalovirus | Clinical Microbiology Reviews
Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future Perspectives - Hodowanec - 2019 - The Journal of Clinical Pharmacology - Wiley Online Library
Letermovir | C29H28F4N4O4 - PubChem
Letermovir - Wikipedia
EX-99.1 2 v379095_ex99-1.htm EXHIBIT 99.1 Exhibit
The human cytomegalovirus terminase complex as an antiviral target: a close-up view. - Abstract - Europe PMC
PDF) Letermovir and inhibitors of the terminase complex: A promising new class of investigational antiviral drugs against human cytomegalovirus
Figure 1 from New therapies for human cytomegalovirus infections. | Semantic Scholar
Letermovir and maribavir for pan‐resistant cytomegalovirus infection in a patient with haematologic malignancy: Consideration for combination therapy - Dickter - - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase | Journal of Virology
Representation of the different anti-CMV antivirals currently in use as... | Download Scientific Diagram
Mechanisms of action of systemic antivirals approved for treatment of... | Download Scientific Diagram
Clinical development of letermovir and maribavir: Overview of human cytomegalovirus drug resistance | Semantic Scholar
Frontiers | The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases | Pharmacology
Letermovir - Wikipedia
![PDF] New therapies for human cytomegalovirus infections. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/07aaa387aabba58c807f4742eefbb7874ade0d0d/48-Figure7-1.png "PDF] New therapies for human cytomegalovirus infections. | Semantic Scholar")
PDF] New therapies for human cytomegalovirus infections. | Semantic Scholar
![PDF] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25353d1c802fba785bea376c53270ab6fd0dd517/6-Figure1-1.png "PDF] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus | Semantic Scholar")
PDF] Letermovir and inhibitors of the terminase complex: a promising new class of investigational antiviral drugs against human cytomegalovirus | Semantic Scholar
Letermovir drug review
New therapies for human cytomegalovirus infections - ScienceDirect
Frontiers | Tuning the Orchestra: HCMV vs. Innate Immunity | Microbiology
